C75 Malignant neoplasm of other endocrine glands and related structures

Name of the Condition

• Malignant neoplasm of other endocrine glands and related structures
• ICD-10 Code: C75

Summary

Malignant neoplasm of other endocrine glands and related structures refers to cancerous growths originating in endocrine glands or associated tissues not classified elsewhere. These glands regulate hormone production, and malignancies can disrupt hormonal balance, leading to systemic health issues. The condition may involve glands such as the parathyroid, adrenal medulla, or other specialized structures.

Causes

The development of this malignancy involves genetic mutations that cause uncontrolled cell growth in endocrine tissues. Contributing factors may include inherited genetic syndromes, environmental exposures, or sporadic mutations. The exact triggers vary depending on the specific gland affected.

Risk Factors

• Genetic syndromes (e.g., Multiple Endocrine Neoplasia)
• Radiation exposure to endocrine areas
• Age (risk increases with age)
• Family history of endocrine or related cancers
• Prior history of endocrine disorders

Symptoms

• Unexplained weight changes
• Fatigue or weakness
• Hormonal imbalances (e.g., electrolyte disturbances, blood pressure changes)
• Pain or swelling in affected glandular regions
• Visible lumps or masses in neck, abdomen, or other areas

Diagnosis

Diagnosis typically involves imaging studies (e.g., CT, MRI, ultrasound) to locate abnormalities, followed by biopsy of suspected tissue to confirm malignancy. Blood tests may assess hormonal levels or tumor markers. Additional scans (e.g., PET) may evaluate spread.

Treatment Options

• Surgical removal of the tumor or affected gland
• Radiation therapy to target remaining cancer cells
• Chemotherapy to inhibit cancer growth
• Hormone therapy to manage imbalances or block tumor-promoting hormones
• Targeted therapies for specific genetic mutations (if applicable)

Prognosis and Follow-Up

Prognosis depends on the specific gland involved, tumor stage, and response to treatment. Regular follow-up includes imaging, blood tests, and clinical evaluations to monitor for recurrence or metastasis. Long-term management may address hormonal deficiencies or complications.

Complications

• Metastasis to other organs or tissues
• Severe hormonal imbalances affecting metabolism, electrolytes, or blood pressure
• Organ dysfunction due to tumor invasion
• Treatment-related side effects (e.g., radiation damage, surgical complications)

Lifestyle & Prevention

• Avoid known carcinogens (e.g., excessive radiation, tobacco)
• Maintain regular health screenings if at high risk
• Manage underlying conditions (e.g., genetic syndromes) with medical guidance
• Promptly address unexplained symptoms to enable early detection

When to Seek Professional Help

Seek care if experiencing persistent symptoms like unexplained weight changes, lumps, or hormonal disturbances. Early evaluation is critical for timely diagnosis and treatment planning.

Tips for Medical Coders

Document the specific endocrine gland or structure involved, as coding requires precise anatomical detail. Include clinical notes on tumor location, histology, and staging to support accurate code assignment. Ensure documentation aligns with ICD-10-CM guidelines for "other" endocrine gland neoplasms.